Skip to main content
. Author manuscript; available in PMC: 2022 Oct 14.
Published in final edited form as: Epilepsia. 2022 Jul 17;63(10):2461–2475. doi: 10.1111/epi.17332

FIGURE 2.

FIGURE 2

Following discovery of SCN8A-related disorders, these were modeled, supported by patient advocacy, and translated into potential treatments, providing an example of relatively efficient progression through the “pipeline” from gene discovery to novel precision medicine approaches. ASO, antisense oligonucleotide.